The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Topic: Diabetes - Primary Care

Wednesday, 13 December 2017
Misdiagnosis of diabetes subtypes is putting the health of people at risk to a new UK study. Researchers examined the primary care records of more than 2 million people, assessing the frequency of different types of diabetes and the accuracy of diagnosis. Particular focus was given to those who developed Type 3c diabetes.
Thursday, 17 January 2019
Approximately one third of all stroke patients have diabetes, according to a large meta-analysis and literature review. Diabetes is associated with poorer stroke outcomes compared with people without diabetes.
Wednesday, 13 December 2017
More than a third of people in the UK are not aware that foot ulcers are a serious complication of diabetes, despite being a leading cause of diabetes-related amputations, according to a survey by YouGov commissioned by Diabetes UK.
Category: Have You Heard
Sunday, 12 March 2017
A new fixed dose combination of saxagliptin (Onglyza) and dapagliflozin (Forxiga) is now available for use in adults with type 2 diabetes.
Category: Have You Heard
Monday, 15 January 2018
We all know that diabetes prevalence is increasing. It is estimated that by 2025, 5 million people will have Type 2 diabetes in the UK (Diabetes UK). That potentially means more pressure on an already creaking healthcare system and more people at risk of developing debilitating complications from their diabetes. It doesn’t have to be that way!
Category: Editorial
Tuesday, 27 February 2018
The prevalence of previously undetected dysglycaemia is high in patients who are free from cardiovascular disease but have one or two other risk factors (hypertension and/or dyslipidaemia). A new study shows that using the FINDRISC questionnaire as a first step of dysglycaemia screening does not provide any benefit in this population.
Monday, 12 September 2016
The time of year is one of a number of factors shown to affect HbA1c levels. This study investigated seasonal variations in HbA1c in a large population of people with diabetes in Scotland. These variations appear to have clinical significance in terms of making medication decisions and other aspects of clinical care.
Category: Editorial
Thursday, 27 October 2016
Semaglutide, an investigational human glucagon-like peptide-1 (GLP-1) analogue, significantly reduced the risk of the primary composite endpoint of time to first occurrence of cardiovascular (CV) death, non-fatal myocardial infarction or non-fatal stroke by 26% vs placebo, when added to standard of care in adults with type 2 diabetes at high CV risk.
Monday, 19 March 2018
A fascinating new study from Sweden and Finland suggests that diabetes is actually five separate diseases and treatment could be tailored for each type. Study authors suggest these findings will usher in a new era of personalised medicine for diabetes.
Thursday, 01 October 2020
The first of 3 interactive programmes providing practical answers about the use of insulin. Jane Diggle and Hannah Beba help to 'demystify' insulin in primary care - what's stopping us and what do we need to know?
Category: Webinars

Article search and filter